ALBANY


Seite 1 von 13
Neuester Beitrag: 25.04.21 01:14
Eröffnet am:16.06.12 17:15von: buranAnzahl Beiträge:319
Neuester Beitrag:25.04.21 01:14von: Christinatpxh.Leser gesamt:42.734
Forum:Hot-Stocks Leser heute:2
Bewertet mit:
4


 
Seite: < 1 | 2 | 3 | 4 |
11 | 12 | 13 13  >  

246516 Postings, 6819 Tage buranALBANY

 
  
    #1
4
16.06.12 17:15
AMRI CFO to Present at 2012 Wells Fargo Securities Healthcare Conference

14:05 12.06.12

PR Newswire

ALBANY, N.Y., June 12, 2012

ALBANY, N.Y., June 12, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the 2012 Wells Fargo Securities Healthcare Conference on Tuesday, June 19, 2012 at 9:30 a.m. ET.

(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO)

An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at www.amriglobal.com. This webcast will be archived for 90 days following the live presentation.

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.  

SOURCE AMRI
Quelle: PR Newswire  
293 Postings ausgeblendet.
Seite: < 1 | 2 | 3 | 4 |
11 | 12 | 13 13  >  

246516 Postings, 6819 Tage buranALBANY, New York, Feb. 12, 2015

 
  
    #295
17.02.15 12:17
AMRI Announces Fourth Quarter and Full Year 2014 Results
13:35 12.02.15

PR Newswire

ALBANY, New York, Feb. 12, 2015
http://www.ariva.de/news/...uarter-and-Full-Year-2014-Results-5283045  

246516 Postings, 6819 Tage buranGabi ist doof!

 
  
    #296
17.02.15 12:18
..sssso

buran & MARIO  

246516 Postings, 6819 Tage buranALBANY, New York, Feb. 12, 2015

 
  
    #297
17.02.15 12:19
AMRI Realigns Global Operations to Enhance Continuous Supply Chain for Customers
22:05 12.02.15

PR Newswire

ALBANY, New York, Feb. 12, 2015

-- Announces Key Leadership Promotions

ALBANY, New York, Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has implemented several changes to further optimize global business operations in order to enhance continuity from early development through to commercial supply and accelerate the company's global growth objectives. http://www.ariva.de/news/...inuous-Supply-Chain-for-Customers-5283602  

246516 Postings, 6819 Tage buranNasdaq Laterne über 272 Tausend Glitzerlinge TOP

 
  
    #298
20.02.15 22:08

3624 Postings, 4222 Tage Cancun25Buran...immer schön atmen unter dem Helm...

 
  
    #299
20.02.15 22:42
soll die Gehirndurchblutung fördern...

also habe ich mal gelesen...  

246516 Postings, 6819 Tage buran16:53 30.03.15 NEW YORK (dpa-AFX)

 
  
    #300
30.03.15 18:59
Frisch angekündigte Übernahmen im Pharmasektor haben die US-Börsen zu Wochenbeginn deutlich angetrieben. Auch Spekulationen über Maßnahmen der chinesischen Regierung zur Stimulierung der dortigen Wirtschaft stützten am Montag die Kurse, sagten Börsianer. http://www.ariva.de/news/...gungen-treiben-die-Wall-Street-an-5324942  

246516 Postings, 6819 Tage buran#00 Der Dow Jones Industrial zog um 1,37 Prozent

 
  
    #301
30.03.15 18:59
auf 17 955,56 Punkte an. In der vergangenen Woche hatte der US-Leitindex noch 2,29 Prozent verloren. Für den marktbreiten S&P-500-Index ging es am Montag um 0,90 Prozent auf 2079,61 Punkte nach oben. An der Nasdaq stieg der technologielastige Auswahlindex Nasdaq 100 (Nasdaq 100) um 0,72 Prozent auf 4363,98 Punkte. http://www.ariva.de/news/...gungen-treiben-die-Wall-Street-an-5324942
 

1247 Postings, 3420 Tage Der Wald@ Cancun:

 
  
    #302
30.03.15 20:33
Wieso Helm ???
In der Gummizelle braucht man doch keinen, alles schön weich u. gepolstert dort ...
COOL
Frag mal das Burani ...
GRINS  

246516 Postings, 6819 Tage buranPR Newswire

 
  
    #304
24.06.15 15:46
AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
14:00 01.05.15

PR Newswire

ALBANY, New York, May 1, 2015

ALBANY, New York, May 1, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015 at 4:20 p.m. ET.

A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2

The webcast will be archived for 90 days following the live presentation.
http://www.ariva.de/news/...Lynch-2015-Health-Care-Conference-5354414  

246516 Postings, 6819 Tage buranAMRI Announces First Quarter 2015 Results

 
  
    #305
24.06.15 15:46

246516 Postings, 6819 Tage buranBUFFALO, New York, June 1, 2015

 
  
    #306
24.06.15 15:47

246516 Postings, 6819 Tage buranBUFFALO, New York, June 17, 2015

 
  
    #307
24.06.15 15:47
AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation and Commercialization Hub
13:05 17.06.15

PR Newswire

BUFFALO, New York, June 17, 2015
http://www.ariva.de/news/...ovation-and-Commercialization-Hub-5396922  

246516 Postings, 6819 Tage buranNasdaq 02-07 im Satz

 
  
    #308
03.07.15 13:07
Datum Erster Hoch Tief Schluss     Stücke Volumen
  02.07.15     19,83     20,09§19,77 19,92 $ 258.079 4,99 M

GrB  

246516 Postings, 6819 Tage buranAMRI Acquires Gadea Pharmaceutical Group

 
  
    #309
20.07.15 17:55
13:35 16.07.15

PR Newswire

ALBANY, N.Y., July 16, 2015

ALBANY, N.Y., July 16, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product. The purchase price was $174 million, including the issuance of 2.2 million shares of common stock to Gadea's owners, valued at $43.8 million, with the balance paid in cash and through the assumption of existing debt. http://www.ariva.de/news/...quires-Gadea-Pharmaceutical-Group-5425080  

246516 Postings, 6819 Tage buranAMRI to Announce Second Quarter 2015 Results

 
  
    #310
25.07.15 05:10
14:05 21.07.15

PR Newswire

ALBANY, N.Y., July 21, 2015

ALBANY, N.Y., July 21, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2015 financial results before the opening of the market on Tuesday, August 4, 2015. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET.

The conference call can be accessed by dialing (866) 208-5728 (domestic calls) or (224) 633-1279 (international calls) at 8:20 a.m. ET and entering passcode 69698467. A live webcast with slides will also be available and can be accessed on the company's website at www.amriglobal.com. A replay of the conference call can be accessed for 24 hours at (855) 859-2056 (domestic calls) or (404) 537-3406 (international calls) and entering passcode 69698467. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at http://ir.amriglobal.com. http://www.ariva.de/news/...ounce-Second-Quarter-2015-Results-5429432  

246516 Postings, 6819 Tage buranAbout AMRI

 
  
    #311
25.07.15 05:11
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing. Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API Manufacturing supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, biologics, peptides, steroids, and cytotoxic compounds. Drug Product Manufacturing supports development through commercial scale production of complex liquid-filled and lyophilized parenteral formulations. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal). http://www.ariva.de/news/...ounce-Second-Quarter-2015-Results-5429432
 

246516 Postings, 6819 Tage burandie Flut kommt:::::

 
  
    #312
30.08.15 08:08
:::::::::::::::: 20,60 $ +3,21% +0,64 $
In Euro: 18,418 € | Nasdaq, 28.08.15 ,GrB  

246516 Postings, 6819 Tage buranRyan & Maniskas, LLP Announces Investigation of

 
  
    #314
12.08.16 10:11
Albany Molecular Research Inc.
Mittwoch, 10.08.2016 18:00 von PR Newswire

       
PR Newswire

WAYNE, Pa., Aug. 10, 2016

WAYNE, Pa., Aug. 10, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Albany Molecular Research, Inc. ("Albany Molecular" or the "Company") (NASDAQ: AMRI). http://www.ariva.de/news/...announces-investigation-of-albany-5843531  

246516 Postings, 6819 Tage buranIf you own shares of Albany Molecular and would

 
  
    #315
12.08.16 10:12
like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/amri. You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com.  http://www.ariva.de/news/...announces-investigation-of-albany-5843531

 

246516 Postings, 6819 Tage buranAlbany Molecular is a contract research and

 
  
    #316
12.08.16 10:13
manufacturing company that provides integrated drug discovery, development and manufacturing services primarily in the United States, Europe and Asia. The complaint alleges that throughout the Class Period defendants misrepresented and/or failed to disclose material adverse facts about the Company's operations, financial performance and prospects, including the Company's financial guidance and operations at its OsoBio facility.

On November 5, 2014, the Company announced weak financial and operating results for third quarter 2014, including an $8.6 million loss in the quarter. The Company attributed the weak third quarter to a "confluence of a business interruption event at our OsoBio facility, together with lower Discovery and API revenue." In addition, the Company disclosed a "weather-related power interruption at our OsoBio facility in Albuquerque took the facility offline for a period of time, contributing to the loss of finished product and the need to remediate one of the suites at the facility." Following this news, Albany Molecular stock declined nearly 27%, or $6.08 per share, to close at $16.59 per share on November 5, 2014.

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. http://www.ariva.de/news/...announces-investigation-of-albany-5843531  

246516 Postings, 6819 Tage buranAMRI CEO to Present at 35th Annual J.P. Morgan

 
  
    #317
03.01.17 20:24
Healthcare Conference
Dienstag, 13.12.2016 14:05 von PR Newswire  http://www.ariva.de/news/...35th-annual-j-p-morgan-healthcare-5979214  

246516 Postings, 6819 Tage buran3ST Research Files Litigation Alleging Fraud and

 
  
    #318
28.09.17 21:02
Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)
Dienstag, 12.09.2017 13:35 von PR Newswire

     
PR Newswire http://www.ariva.de/news/...ion-alleging-fraud-and-conversion-6463694

 

9 Postings, 1098 Tage ChristinatpxhaLöschung

 
  
    #319
25.04.21 01:14

Moderation
Zeitpunkt: 26.04.21 10:27
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Spam

 

 

Seite: < 1 | 2 | 3 | 4 |
11 | 12 | 13 13  >  
   Antwort einfügen - nach oben